Elder Project Ltd
Elder Project Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in Pharmaceutical Manufacturing activities
- Market Cap ₹ Cr.
- Current Price ₹ 20.2
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -11.4
- Dividend Yield 0.00 %
- ROCE 9.96 %
- ROE -29.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 49.6 to 28.0 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.54% over past five years.
- Company has a low return on equity of -11.3% over last 3 years.
- Earnings include an other income of Rs.1.63 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 15m | TTM | |
---|---|---|---|---|---|---|---|---|---|
11.72 | 3.10 | 4.88 | 5.62 | 6.84 | 8.62 | 9.71 | 6.39 | 2.43 | |
11.58 | 3.39 | 4.66 | 5.04 | 5.53 | 6.37 | 7.52 | 4.92 | 2.59 | |
Operating Profit | 0.14 | -0.29 | 0.22 | 0.58 | 1.31 | 2.25 | 2.19 | 1.47 | -0.16 |
OPM % | 1.19% | -9.35% | 4.51% | 10.32% | 19.15% | 26.10% | 22.55% | 23.00% | -6.58% |
4.06 | 0.82 | 0.99 | 2.21 | 0.54 | 0.63 | 1.51 | 1.53 | 1.63 | |
Interest | 1.48 | 1.70 | 1.60 | 3.67 | 1.96 | 2.26 | 2.80 | 2.68 | 3.60 |
Depreciation | 0.37 | 0.40 | 0.53 | 0.54 | 0.55 | 0.58 | 0.60 | 0.60 | 0.52 |
Profit before tax | 2.35 | -1.57 | -0.92 | -1.42 | -0.66 | 0.04 | 0.30 | -0.28 | -2.65 |
Tax % | 7.66% | -36.94% | -66.30% | 16.90% | -1.52% | 175.00% | 83.33% | 25.00% | |
2.17 | -0.99 | -0.31 | -1.66 | -0.65 | -0.03 | 0.06 | -0.34 | -2.64 | |
EPS in Rs | 6.71 | -3.06 | -0.96 | -5.13 | -2.01 | -0.09 | 0.19 | -1.05 | -8.16 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | -2% |
TTM: | 58% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -20% |
3 Years: | 6% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | -2% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -26% |
3 Years: | -11% |
Last Year: | -29% |
Balance Sheet
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 |
Reserves | 2.32 | 1.33 | 1.02 | -0.64 | -1.29 | -1.32 | -1.27 | -1.61 |
15.20 | 21.36 | 35.35 | 28.17 | 15.64 | 18.72 | 20.96 | 20.03 | |
3.02 | 2.99 | 4.47 | 1.95 | 4.26 | 1.43 | 1.80 | 2.91 | |
Total Liabilities | 23.77 | 28.91 | 44.07 | 32.71 | 21.84 | 22.06 | 24.72 | 24.56 |
5.06 | 6.15 | 6.71 | 6.40 | 6.02 | 6.25 | 6.09 | 4.43 | |
CWIP | 0.00 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 7.33 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.39 |
11.38 | 14.75 | 30.02 | 18.97 | 8.48 | 8.47 | 11.29 | 12.74 | |
Total Assets | 23.77 | 28.91 | 44.07 | 32.71 | 21.84 | 22.06 | 24.72 | 24.56 |
Cash Flows
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|
-0.27 | -9.14 | -10.81 | 16.24 | 4.52 | 9.24 | 2.95 | 1.51 | |
0.67 | -1.99 | -0.03 | -0.06 | 0.36 | -0.58 | -1.08 | 0.95 | |
-0.33 | 11.18 | 12.99 | -8.79 | -14.49 | -8.69 | -1.75 | -2.68 | |
Net Cash Flow | 0.07 | 0.05 | 2.15 | 7.39 | -9.61 | -0.03 | 0.12 | -0.22 |
Ratios
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 70.38 | 50.63 | 11.97 | 14.94 | 13.34 | 34.30 | 86.46 | 27.99 |
Inventory Days | 20.38 | 691.58 | 189.80 | 192.75 | 180.66 | 149.59 | 150.94 | |
Days Payable | 129.46 | 1,460.00 | 428.27 | 463.43 | 412.93 | 329.10 | 359.51 | |
Cash Conversion Cycle | -38.70 | -717.79 | -226.50 | -255.74 | -218.93 | -145.21 | -122.11 | 27.99 |
Working Capital Days | 245.72 | 1,256.31 | 1,626.05 | 382.54 | 143.01 | 21.17 | 84.95 | 84.54 |
ROCE % | 0.56% | 2.08% | 6.40% | 5.38% | 12.14% | 13.46% | 9.96% |
Documents
Announcements
-
Statement Of Investor Complaints For The Quarter Ended March 2018
17 May 2018 - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter …
- Board Meeting-Outcome of Board Meeting 23 Feb 2018
- Board Meeting To Be Held On 23Rd February 2018. 19 Feb 2018
- Outcome of Board Meeting 10 Mar 2016
- Board Meeting on March 10, 2016 1 Mar 2016